ADVERTISEMENT

cardiotoxicity

Research in Review

Cardiotoxicity Among Childhood Cancer Survivors Decreasing Over Time

01/24/2017

JCP Editors

Initiatives to reduce cardiotoxicity among childhood patients with cancer treated more recently have had a measurable impact over time, according to research published in Circulation. ----- Related Content Risk of...

Initiatives to reduce cardiotoxicity among childhood patients with cancer treated more recently have had a measurable impact over time, according to research published in Circulation. ----- Related Content Risk of...

...

01/24/2017

Journal of Clinical Pathways

Research in Review

Trastuzumab-Related Cardiotoxicity Prevented In Patients With Breast Cancer

11/30/2016

JCP Editors

Two kinds of heart medications, angiotensin-converting enzyme (ACE) inhibitors and beta blockers, can help to prevent a decline in heart function from breast cancer treatment, according to new research published in...

Two kinds of heart medications, angiotensin-converting enzyme (ACE) inhibitors and beta blockers, can help to prevent a decline in heart function from breast cancer treatment, according to new research published in...

Two...

11/30/2016

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22

AMP Europe

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

October 29 ⁠–⁠ November 2

See Full Calendar

Advertisement

Advertisement